Literature DB >> 30344900

NLRP3 Modulators for the Treatment of Autoinflammatory Disorders.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2018        PMID： 30344900      PMCID： PMC6187397          DOI： 10.1021/acsmedchemlett.8b00416

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome.

Authors:  Raffaella Mastrocola; Manuela Aragno; Giuseppe Alloatti; Massimo Collino; Claudia Penna; Pasquale Pagliaro
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

Review 2.  Ion homeostasis and ion channels in NLRP3 inflammasome activation and regulation.

Authors:  Iva Hafner-Bratkovič; Pablo Pelegrín
Journal:  Curr Opin Immunol       Date:  2018-03-16       Impact factor: 7.486

Review 3.  Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.

Authors:  Sadaf Jahan; Dipak Kumar; Swati Chaturvedi; Mamunur Rashid; Muhammad Wahajuddin; Yasir A Khan; Sameer N Goyal; C R Patil; Rajesh Mohanraj; Sandeep Subramanya; Shreesh Ojha
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 4.  Post-translational regulation of inflammasomes.

Authors:  Jie Yang; Zhonghua Liu; Tsan Sam Xiao
Journal:  Cell Mol Immunol       Date:  2016-06-27       Impact factor: 11.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.